Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Precision Genomic Testing Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The precision genomic testing market has seen rapid expansion in recent years. Its value is projected to increase from $13.44 billion in 2024 to $15.00 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.6%. The historical surge in this market is largely due to the expanding availability of direct-to-consumer genetic tests, increased partnerships between pharmaceutical and diagnostic firms, a greater emphasis on preventive healthcare, the rising acceptance of companion diagnostics, and growing understanding regarding early disease detection.
The precision genomic testing market size is anticipated to expand rapidly over the next few years. It is projected to reach $23.11 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.4%. This growth during the forecast period is fueled by an increasing need for precision oncology solutions, a heightened emphasis on diagnostics for rare diseases, greater investment in population genomics initiatives, the expanding adoption of multi-omics approaches, and a growing demand for non-invasive prenatal testing. Significant trends expected in this period encompass advancements in next-generation sequencing technologies, novelties in liquid biopsy techniques, the integration of artificial intelligence into genomic analysis, progress in multi-omics data interpretation, and innovations in direct-to-consumer genetic testing models.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25883&type=smp
What Are The Drivers Pushing New Developments In The Precision Genomic Testing Market?
The increasing occurrence of genetic conditions is anticipated to drive expansion in the precision genomic testing market. These disorders are defined as health issues resulting from anomalies in an individual’s DNA, including single-gene mutations, multi-gene mutations, or alterations in chromosome structure or count. This rising prevalence is largely attributed to advancing maternal age, given that older mothers face an elevated risk of transmitting chromosomal abnormalities, like Down syndrome, to their offspring. Precision genomic testing facilitates the prompt identification and precise diagnosis of genetic disorders through the detection of specific genetic mutations, thereby enabling focused interventions and customized treatment approaches. As an illustration, Gene People, a registered charity based in the UK, reported in May 2025 that an estimated 1 in 25 children are affected by genetic conditions, influencing more than 2.4 million children and adults across the UK. Furthermore, approximately 30,000 newborns and children in the UK receive a diagnosis for a genetic condition annually. Consequently, the increasing prevalence of genetic disorders is fueling the expansion of the precision genomic testing market.
What Are The Major Segment Types Covered In The Precision Genomic Testing Market?
The precision genomic testing market covered in this report is segmented –
1) By Product And Service: Consumables, Equipment, Services
2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray Technology, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats Or Clustered Regularly Interspaced Short Palindromic Repeats-Associated Systems, Other Technologies
3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Reproductive Health, Rare Diseases, Other Applications
4) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End-Users
Subsegments:
1) By Consumables: Reagents And Kits, Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Library Preparation Kits, Sequencing Reagents, Polymerase Chain Reaction Assay Kits, Buffers And Enzymes
2) By Equipment: Next-Generation Sequencing Systems, Polymerase Chain Reaction Machines, Microarray Instruments, Deoxyribonucleic Acid Analyzers, Bioinformatics Workstations, Laboratory Automation Systems
3) By Services: Genomic Data Analysis Services, Laboratory Testing Services, Genetic Counseling Services, Clinical Interpretation Services, Contract Research Services, Custom Assay Development Services
What Are The Major Trends Driving The Growth Of The Precision Genomic Testing Market?
Leading companies in the precision genomic testing market are concentrating on developing innovative solutions, such as ultra-sensitive circulating tumor deoxyribonucleic acid (DNA) assays, to facilitate earlier and more accurate cancer detection. These ultra-sensitive circulating tumor DNA assays are advanced tests designed to identify tiny fragments of tumor-derived DNA in the blood, enabling prompt and precise identification of cancer-related genetic mutations. For instance, in April 2025, Natera Inc., a US-based clinical genetic testing company, launched its ultra-sensitive Signatera genome molecular residual disease test. This test leverages whole genome sequencing of both a patient’s tumor and matched normal DNA to create a personalized assay, allowing for the detection of circulating tumor DNA at extremely low levels, as minute as 1 part per million. This high level of sensitivity critically supports earlier and more precise detection of cancer recurrence, thereby enhancing treatment planning and patient management across various cancer types.
Which Global Market Leaders Are Shaping The Future Of The Precision Genomic Testing Sector?
Major companies operating in the precision genomic testing market are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Ambry Genetics Corporation, Color Health Inc., Pacific Biosciences, Eurofins Genomics LLC, Precision Genetics.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/precision-genomic-testing-global-market-report
Which Region Is Expected To Witness The Fastest Growth In The Precision Genomic Testing Market?
North America was the largest region in the precision genomic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision genomic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Precision Genomic Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25883&type=smp
Browse Through More Reports Similar to the Global Precision Genomic Testing Market 2025, By The Business Research Company
Genetic Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report
Dna Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report
Genomics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genomics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model